Active Pharmaceutical Ingredients APIs

• Item Code: ACECCE001M
• Production Capacity: 50 MT
• Delivery Time: 3-5 Days
• Packaging Details: Sealed Intact HDPE/Fibre drum

• Item Code: BFTCE
• Pay Mode Terms: L/C (Letter of Credit),T/T (Bank Transfer),Other
• Port of Dispatch: Ahmedabad
• Production Capacity: Any
• Delivery Time: 4-6 Days

• IUPAC ID: 5H-dibenzo[b,f]azepine-5-carboxamide
• Metabolism: Hepatic—by CYP3A4, to active epoxide form (carbamazepine-10,11 epoxide)
• Biological half-life: 36 hours (single dose), 16-24 hours (repeated dosing)
• DrugBank: DB00564
• License data: US Daily Med: 8d409411-aa9f-4f3a-a52c-fbcb0c3ec053

• Pay Mode Terms: L/C (Letter of Credit),T/T (Bank Transfer),Other
• Port of Dispatch: Ahmedabad
• Production Capacity: Any
• Delivery Time: 5-7 Days

• IUPAC ID: (2S)-2-[(4-{[(2-amino-4-hydroxypteridin-6-yl)methyl]amino}phenyl)formamido]pentanedioic acid

Methylcobalamin Vitamin B12 (mecobalamin, MeCbl, or MeB12) is a cobalamin, a form of vitamin B12. It differs from cyanocobalamin in that the cyano at the cobalt is replaced with a methyl group. Methylcobalamin features an octahedral cobalt(III) centre and can be obtained as bright red crystals. From the perspective of coordination chemistry, methylcobalamin is notable as a rare example of a compound that contains metal-alkyl bonds. Nickel-methyl intermediates have been proposed for the final step of methanogenesis.

Methylcobalamin is equivalent physiologically to vitamin B12 and can be used to prevent or treat pathology arising from a lack of vitamin B12 (vitamin B12 deficiency), such as pernicious anemia.

Methylcobalamin is also used in the treatment of peripheral neuropathy, diabetic neuropathy, and as a preliminary treatment for amyotrophic lateral sclerosis.

Methylcobalamin that is ingested is not used directly as a cofactor but is first converted by MMACHC into cob(II)alamin. Cob(II)alamin is then later converted into the other 2 forms, adenosylcobalamin and methylcobalamin for use as cofactors. That is, methylcobalamin is first dealkylated and then regenerated.

One author says it is important to treat vitamin B12 deficiency with hydroxocobalamin or cyanocobalamin or a combination of adenosylcobalamin and methylcobalamin, and not methylcobalamin alone.

• Pay Mode Terms: T/T (Bank Transfer),Cheque
• Port of Dispatch: Ahmedabad
• Production Capacity: 200 kgs
• Delivery Time: 2-5 Days

• InChI Key: JZRWCGZRTZMZEH-UHFFFAOYSA-N
• Unit: 4ABT0J945J
• EC Number: 200-425-3
• Canonical Smiles: CC1=C(SC [N+]1CC2=CN=C(N=C2N)C)CCO
• InChI: 1S/C12H17N4OS+/ c1-8-11 (3-4-17) 18-7-16 (8) 6-10-5-14-9 (2) 15-12 (10) 13/h5, 7, 17H, 3-4, 6H2, 1-2H3, (H2,13,14,15)/q+1
• IUPAC Name: 2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1, 3-thiazol-3-ium-5-yl]ethanol

Being a well-established organization, we are engaged in offering a distinguished range of Ascorbic Acid IP-BP-USP-EP Vitamin C (Plain / Coated).

Ascorbic Acid Details:

pH (5% w/v): 2.1-2.6

Specific optical rotation: 20.5-21.5 degree

Clarity and color: Clear < 7

Copper: < 0.0003%

Heavy metals: < 0.001%

Iron: < 0.0002%

Mercury: < 0.0001%

Zinc: < 0.00025%

Arsenic: < 0.0003%

Lead: < 0.0002%

Oxalic acid: < 0.2%

Loss on Drying: < 0.1%

Sulphated ash: < 0.1%

Assay: 99.0% - 100.5%

Types of Ascorbic acid available:

Ascorbic acid plain

Ascorbic acid coated

ALL IP/BP/USP Grades

• Port of Dispatch: Narol
• Production Capacity: 5000 kgs
• Delivery Time: 5-7 Days
• Packaging Details: 25 kg Drum/Bag

• UNII: 0MP32MFP6C
• IUPAC Name: 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid;hydrochloride
• InChI: InChI=1S/C17H18FN3O3.ClH/c18-13-7-11-14(8-15(13)20-5-3-19-4-6-20)21(10-1-2-10)9-12(16(11)22)17(23)24;/h7-10,19H,1-6H2,(H,23,24);1H
• Canonical SMILES: C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O.Cl
• InChI Key: DIOIOSKKIYDRIQ-UHFFFAOYSA-N

• IUPAC Name: sodium;2-[2-(2,6-dichloroanilino)phenyl]acetate
• InChI: InChI=1S/C14H11Cl2NO2.Na/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19;/h1-7,17H,8H2,(H,18,19);/q;+1/p-1
• InChI Key: KPHWPUGNDIVLNH-UHFFFAOYSA-M
• Canonical SMILES: C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl.[Na+]
• UNII: QTG126297Q

• Item Code: CEVE01
• Port of Dispatch: Narol
• Delivery Time: 5-7 Days
• Packaging Details: 25 kg drum/bag

• License data: US FDA: Adapalene
• Drug Bank: DB00210
• Bioavailability: Very low

• Item Code: ADACE001
• Pay Mode Terms: L/C (Letter of Credit),T/T (Bank Transfer),Other
• Port of Dispatch: Ahmedabad
• Production Capacity: 500 kgs
• Delivery Time: 4-6 Days

• Description: Calcium channel blocker
• Alternative Names: KW 3049
• Chemical Name: (4R)-rel-1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-[(3R)-1-(phenylmethyl)-3-piperidinyl]yridinedicarboxylic acid 3-methyl 5-[(3R)-1-(phenylmethyl)-3-piperidinyl] ester hydrochloride
• Storage: Desiccate at RT
• InChI Key: SPMJXDRNJQIBTB-IMEZZWDRSA-N

• Item Code: BENCE
• Pay Mode Terms: L/C (Letter of Credit),T/T (Bank Transfer),Other
• Port of Dispatch: Ahmedabad
• Production Capacity: Any
• Delivery Time: 4-6 Days

• PubChem CID: 5282138

• IUPAC Name: (5R,6S)-3-[2-(aminomethylideneamino)ethylsulfanyl]-6-[(1R)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
• InChI: InChI=1S/C12H17N3O4S/c1-6(16)9-7-4-8(20-3-2-14-5-13)10(12(18)19)15(7)11(9)17/h5-7,9,16H,2-4H2,1H3,(H2,13,14)(H,18,19)/t6-,7-,9-/m1/s1
• InChI Key: ZSKVGTPCRGIANV-ZXFLCMHBSA-N
• Canonical SMILES: CC(C1C2CC(=C(N2C1=O)C(=O)O)SCCN=CN)O
• Isomeric SMILES: C[C@H]([C@@H]1[C@H]2CC(=C(N2C1=O)C(=O)O)SCCN=CN)O
• EC Number: 264-734-5
• UNII: Q20IM7HE75

• IUPAC Name: 2-[2-[bis(2-oxido-2-oxoethyl)amino]ethyl-(carboxymethyl)amino]acetate; iron(3+)oethyl)amino]acetate; iron(3+)
• Description: Reddish brown coloured fine, free-flowing spray dried powder.
• Ph of 10 % solution: 6. 85 (5. 50-8. 5 0 at 27°c. )
• Loss on drying: 2. 17%% (NMT 8. 00 % w/w as estimated by aoac method. )
• Chemical parameter: (on dry wt. Basis)
• Ionised/ free iron (iii): Negative.
• Iron (iii) bound: Positive.
• Total elemental iron: 34. 13% (nlt 25 % )
• Heavy metals: < 200 ppm.
• Maltose contain: 31. 09 % (25 to 50 %)

• Total plate count: NMT 10,000 CFU per gram.

• Itopride is a prokinetic benzamide derivative unlike metoclopramide or domperidone. These drugs inhibit dopamine and acetylcholine esterase enzyme and have a gastrokinetic effect.

• This acid is the primary biologically active form of folate used at the cellular level for DNA reproduction, the cysteine cycle and the regulation of homocysteine.

• IUPAC ID: (2S)-2-[ [4-[(2-Amino-5-methyl-4-oxo-1,6,7,8-tetrahydropyridine-6-yr) methylamino]benzoyl]amino]pentanedioic acid

• InChI Key: XEONAUVPDJSDIH-UHFFFAOYSA-N
• Canonical Smiles: C[Si](C)(C)O[Si](C)(C)C.O=[Si]=O
• InChI: InChI=1S/C6H18OSi2.O2Si/c1-8(2,3)7-9(4,5)6;1-3-2/h1-6H3;
• IUPAC Name: dioxosilane trimethyl (trimethylsilyloxy) silane

• InChI Key: ZZIZZTHXZRDOFM-XFULWGLBSA-N
• UNII: 11SV1951MR
• EC Number: 617-011-7
• CAS: 80223-99-0/106463-17-6
• Isomeric SMILES: CCOC1=CC=CC=C1OCCN[C@H](C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N.Cl
• Canonical SMILES: CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N.Cl
• InChI: InChI=1S/C20H28N2O5S.ClH/c1-4-26-17-7-5-6-8-18(17)27-12-11-22-15(2)13-16-9-10-19(25-3)20(14-16)28(21,23)24;/h5-10,14-15,22H,4,11-13H2,1-3H3,(H2,21,23,24);1H/t15-;/m1./s1
• IUPAC Name: 5-[(2R)-2-[2-(2-ethoxyphenoxy) ethylamino]propyl]-2-methoxybenzenesulfonamide hydrochloride

• InChI Key: DOMXUEMWDBAQBQ-WEVVVXLNSA-N
• Unit: G7RIW8S0XP
• Canonical Smiles: CC(C)(C)C#CC=CCN (C) CC1=CC=CC2=CC=CC=C21
• InChI: =1S/C21H25N/c1-21(2,3)15-8-5-9-16-22(4)17-19-13-10-12-18-11-6-7-14-20(18)19/h5-7,9-14H,16-17H2,1-4H3/b9-5+
• IUPAC Name: (E)-N,6,6-trimethyl-N-(naphthalen-1-ylmethyl)hept-2-en-4-yn-1-amine

• InChI Key: FORFDCPQKJHEBF-VPUSDGANSA-N
• Isomeric SMILES: CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC
• Canonical SMILES: CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCC=C\CC=C\CCCCC
• InChI: InChI=1S/C44H84NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-43(46)50-40-42(41-52-54(48,49)51-39-38-45(3,4)5)53-44(47)37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h15,17,21,23,42H,6-14,16,18-20,22,24-41H2,1-5H3/b17-15-,23-21-/t42-/m1/s1
• IUPAC Name: [(2R)-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

• Simethicone Emulsion USP SME 300 is a 30% active emulsion of Simethicone USP, specially formulated to be used in food and pharma industry as an antifoam. It is recommended for use as an antiflatulent additive in antacid and digestive enzymatic preparations.
• It is also recommended to be used as an antiflatulent additive in aqueous formulations such as suspensions and digestive enzymatic preparations. The dosage varies and has to be optimized depending upon the type of industry, medium in which the antifoam is added, an intensity of the foam etc.

• Excellent defoaming and anti-foaming properties
• Superior performance at broad pH range
• Good dispersibility in aqueous systems
• Chemically inert and non-toxic and user-friendly
• Good temperature stability

• IUPAC Name: 2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]ethanol;dihydrochloride
• InChI: InChI=1S/C21H27ClN2O2.2ClH/c22-20-8-6-19(7-9-20)21(18-4-2-1-3-5-18)24-12-10-23(11-13-24)14-16-26-17-15-25;;/h1-9,21,25H,10-17H2;2*1H
• InChI Key: ANOMHKZSQFYSBR-UHFFFAOYSA-N
• Canonical SMILES: C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.Cl.Cl
• EC Number: 218-586-3

• PubChem CID: 688272

• PubChem CID: 9933004
• InChI Key: JWEXHQAEWHKGCW-UHFFFAOYSA-N
• Canonical SMILES: C1CC2=C(C=CC(=C2)F)OC1C(CNCC(C3CCC4=C(O3)C=CC(=C4)F)O)O.Cl
• InChI: InChI=1S/C22H25F2NO4.ClH/c23-15-3-7-19-13(9-15)1-5-21(28-19)17(26)11-25-12-18(27)22-6-2-14-10-16(24)4-8-20(14)29-22;/h3-4,7-10,17-18,21-22,25-27H,1-2,5-6,11-12H2;1H
• IUPAC Name: 1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)-2-[[2-(6-fluoro-3,4-dihydro-2H-chromen-2-yl) 2-hydroxyethyl] amino]ethanol, hydrochloride

• Molecular Formula: C29H39N5O8
• Molecular Weight: 585.658 g/mol
• InChI Key: SOVUOXKZCCAWOJ-HJYUBDRYSA-N
• UNII: 70JE2N95KR
• CAS: 220620-09-7
• Isomeric SMILES: CC(C)(C)NCC(=O)NC1=C(C2=C(C[C@H]3C[C@H]4[C@@H](C(=O)C(=C([C@]4(C(=O)C3=C2O)O)O)C(=O)N)N(C)C)C(=C1)N(C)C)O
• Canonical SMILES: CC(C)(C)NCC(=O)NC1=C(C2=C(CC3CC4C(C(=O)C(=C(C4(C(=O)C3=C2O)O)O)C(=O)N)N(C)C)C(=C1)N(C)C)O
• InChI: InChI=1S/C29H39N5O8/c1-28(2,3)31-11-17(35)32-15-10-16(33(4)5)13-8-12-9-14-21(34(6)7)24(38)20(27(30)41)26(40)29(14,42)25(39)18(12)23(37)19(13)22(15)36/h10,12,14,21,31,36-37,40,42H,8-9,11H2,1-7H3,(H2,30,41)(H,32,35)/t12-,14-,21-,29-/m0/s1
• IUPAC Name: (4S,4aS,5aR,12aR)-9-[[2-(tert-butylamino)acetyl]amino]-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide